Clinical Trial Update: Effect of Glucagon-like Peptide 1 (GLP-1) on Microvascular Myocardial Function in Patients With Type 2 Diabetes. [Phase 4]

View source ↗

Summary

Phase 4 trial update noting completion of a study evaluating the effect of glucagon-like peptide-1 (GLP-1) on microvascular myocardial function in patients with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Microvascular Dysfunction
• Type 2 Diabetes Mellitus

Drugs mentioned

• Glucagon-like peptide-1 (GLP-1) (glucagon-like peptide-1)

Snippet

Sponsor: Bispebjerg Hospital | Conditions: Type 2 Diabetes, Microvascular Dysfunction | Phase 4 | Status: COMPLETED